Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis.
about
Understanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease ProgressionMonoclonal antibodies against autocrine motility factor suppress gastric cancer.Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.Evodiamine Induces Apoptosis and Inhibits Migration of HCT-116 Human Colorectal Cancer CellsAMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinomaTIM-3 expression in human osteosarcoma: Correlation with the expression of epithelial-mesenchymal transition-specific biomarkersZEB2 Represses the Epithelial Phenotype and Facilitates Metastasis in Ewing Sarcoma.Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations.EMT- and MET-related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities.Natural product pectolinarigenin inhibits osteosarcoma growth and metastasis via SHP-1-mediated STAT3 signaling inhibition.Genetic factors conferring metastasis in osteosarcoma.Non-metabolic functions of glycolytic enzymes in tumorigenesis.Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor.hTERT promoter activity identifies osteosarcoma cells with increased EMT characteristics.Tetrahydrocurcumin induces mesenchymal-epithelial transition and suppresses angiogenesis by targeting HIF-1α and autophagy in human osteosarcoma.A novel binding of GTP stabilizes the structure and modulates the activities of human phosphoglucose isomerase/autocrine motility factor.CEACAM6 is associated with osteosarcoma metastasis and facilitates epithelial-mesenchymal transition in osteosarcoma cells.
P2860
Q26829949-3640054B-2004-40A8-ABD4-88C3B2779D34Q33751147-EEF781DA-E6FA-4C15-A45D-32CA57692245Q34899974-61AA248C-4623-4FF4-B5CF-1B7085B36834Q35845158-CC449F11-6C6F-4892-BF02-447332DE5D78Q36413463-74040194-67B6-4FBC-A055-7C724C23D2AFQ37211620-FB41A6DF-23CF-4EC3-9BB0-69CC5E1168E9Q37424383-C9E09DCC-B38A-4380-88A6-6402792E535CQ37885165-6376F552-4D05-4FD7-97E1-CF34F8AF7153Q38677439-FEAD4B45-5B08-4E50-B139-5CDF3D4641A1Q38741382-B1AA013B-A820-4033-A44D-B0B187E25487Q38806986-40FAE62E-99BC-4DB8-BCB3-4B87A9547A95Q38994977-4E3EA5AD-2F50-4991-AF28-497A9929A8C6Q39268116-6810FA59-7CBC-4A23-B131-671BDAA9F1FDQ42133161-914115BD-FFD9-4901-B659-DEB462E46F65Q47107018-5D8E63F2-8780-4E04-A703-805EFD6270D0Q47674806-1B1CFDDE-5155-4B27-A44F-1757B3D2614BQ55003874-AD038101-46FA-45D9-9E75-01778B279BBB
P2860
Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Silencing of autocrine motilit ...... osarcoma pulmonary metastasis.
@ast
Silencing of autocrine motilit ...... osarcoma pulmonary metastasis.
@en
Silencing of autocrine motilit ...... osarcoma pulmonary metastasis.
@nl
type
label
Silencing of autocrine motilit ...... osarcoma pulmonary metastasis.
@ast
Silencing of autocrine motilit ...... osarcoma pulmonary metastasis.
@en
Silencing of autocrine motilit ...... osarcoma pulmonary metastasis.
@nl
prefLabel
Silencing of autocrine motilit ...... osarcoma pulmonary metastasis.
@ast
Silencing of autocrine motilit ...... osarcoma pulmonary metastasis.
@en
Silencing of autocrine motilit ...... osarcoma pulmonary metastasis.
@nl
P2093
P2860
P1433
P1476
Silencing of autocrine motilit ...... osarcoma pulmonary metastasis.
@en
P2093
Arayo Haga
Avraham Raz
Kiyoshi Harada
Masahiro Fujimuro
Masamitsu Oda
Masashi Yamashiro
Misa Hosoki
Naoya Arai
Narikazu Uzawa
Satoshi Yamaguchi
P2860
P304
P356
10.1158/0008-5472.CAN-09-3880
P407
P577
2010-10-26T00:00:00Z